Thanasis Vlachopiotis is Head of Market Access & Government Affairs for Greece, Cyprus and Malta at AbbVie. He has extensive experience in the pharmaceutical industry, specializing in market access, pricing and reimbursement, government affairs, and the value proposition of therapies. His career includes roles at AbbVie, Medison Pharma, Genesis Pharma, the Greek Ministry of Health, Apervis HealthCare, and Bristol Myers Squibb.

Before taking up his current position, he served as Government Affairs & Market Access Manager for Medison Pharma’s South Cluster European Partner Markets and as Market Access Value Proposition Manager in Hematology at AbbVie. He has also held Market Access and Pricing & Reimbursement role at Genesis Pharma and served as Minister’s advisor at the Greek Ministry of Health.

He holds an MSc in Leadership, Innovation and Value-Based Health Policies from the University of West Attica and an MBA from the University of Piraeus. 

He is also serving as Vice President of ELEMA (Hellenic Market Access Association), a scientific, non-profit Greek association dedicated to advancing the role of market access in medicines, dietary supplements, and health technologies.